PRIOVANT

Serial Number 97261339
Registration 6924850
700

Registration Progress

Application Filed
Feb 10, 2022
Under Examination
Approved for Publication
Sep 27, 2022
Published for Opposition
Sep 27, 2022
Registered
Dec 13, 2022

Trademark Image

PRIOVANT

Basic Information

Serial Number
97261339
Registration Number
6924850
Filing Date
February 10, 2022
Registration Date
December 13, 2022
Published for Opposition
September 27, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 13, 2022
Registration
Registered
Classes
005 042 044

Rights Holder

PRIOVANT THERAPEUTICS, INC.

03
Address
151 W. 42ND STREET
15TH FLOOR
NEW YORK, NY 10036

Ownership History

Roivant Sciences GmbH

Original Applicant
99
Basel CH

Roivant Sciences GmbH

Owner at Publication
99
Basel CH

Roivant Sciences GmbH

Original Registrant
99
Basel CH

PRIOVANT THERAPEUTICS, INC.

New Owner After Registration #1
03
NEW YORK, NY

Legal Representation

Attorney
Lisa L. Mueller

USPTO Deadlines

Next Deadline
1239 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-12-13)
Due Date
December 13, 2028
Grace Period Ends
June 13, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Mar 1, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Mar 1, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 1, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 13, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 13, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 13, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 27, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 27, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 7, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 18, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 17, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 17, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 17, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 17, 2022 ALIE A ASSIGNED TO LIE Loading...
Aug 17, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 21, 2022 CNFR R FINAL REFUSAL WRITTEN Loading...
Jul 21, 2022 GNFR O FINAL REFUSAL E-MAILED Loading...
Jul 21, 2022 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jul 14, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 13, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 13, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 27, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 27, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 27, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 27, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 14, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use, namely, for the prevention and treatment of immunological, auto-immune, rheumatological, dermatological and oncological diseases and disorders; biological preparations for medical and therapeutic purposes, namely, for the prevention and treatment of immunological, auto-immune, rheumatological, dermatological and oncological diseases and disorders
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceutical and biomedicine; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042 044